Nakornthon Hospital PCL (BKK:NKT) Research & Development: ฿0 Mil (TTM As of Mar. 2026)


BKK:NKT Nakornthon Hospital PCL BKK:NKT
19 GF Score
Price ฿3.76
! 5 Warning Signs
View Full Analysis

What is Nakornthon Hospital PCL Research & Development?

Nakornthon Hospital PCL BKK:NKT -1.57% 19 Research & Development is ฿0 Mil as of Mar. 2026. GuruFocus rates BKK:NKT with a GF Score™ of 19/100. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Nakornthon Hospital PCL's Research & Development for the three months ended in Mar. 2026 was ฿0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ฿0 Mil.

Nakornthon Hospital PCL  (BKK:NKT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nakornthon Hospital PCL Research & Development Related Terms

Nakornthon Hospital PCL Research & Development Historical Data

* Premium members only.

The historical data trend for Nakornthon Hospital PCL's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nakornthon Hospital PCL Research & Development Chart

Nakornthon Hospital PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00 0.00

Nakornthon Hospital PCL Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BKK:NKT
19GF Score
Nakornthon Hospital PCL BKK:NKT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nakornthon Hospital PCL Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ฿0 Mil mean?
Nakornthon Hospital PCL (BKK:NKT) has a Research & Development of ฿0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Nakornthon Hospital PCL and its competitors.
Is Nakornthon Hospital PCL's Research & Development too high?
Nakornthon Hospital PCL's current Research & Development is ฿0 Mil. Overall, Nakornthon Hospital PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Nakornthon Hospital PCL's Research & Development compare to HCA and THC?
Nakornthon Hospital PCL's Research & Development of ฿0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nakornthon Hospital PCL and its competitors. Nakornthon Hospital PCL's current Research & Development is ฿0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nakornthon Hospital PCL stock overvalued right now?
Nakornthon Hospital PCL (BKK:NKT) has a current Research & Development of ฿0 Mil. The current Research & Development is ฿0 Mil. Nakornthon Hospital PCL's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nakornthon Hospital PCL (BKK:NKT), the current Research & Development is ฿0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nakornthon Hospital PCL Business Description

Address 1 Soi Rama II, Soi 56, Samaedum Subdistrict, Bang Khun Thian District, Bangkok, THA, 10150
Nakornthon Hospital PCL is engaged in the healthcare industry. It is principally engaged in the hospital business offering specialty centers such as Orthopedics Center, Neurology Center, Gastrointestinal and Liver Center, and Nakornthon Fertility Center by Superior A.R.T. The company has two reportable segments which are hospital operations and other businesses that support hospital business including distribution of health and cosmetic products, facility management, and restaurant. A majority of its revenue is generated from the hospital business. Its operations are carried on in the geographical area of Thailand.
19GF Score

Get the complete analysis for BKK:NKT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿3.76
Price